Possible Involvement of Glutamatergic, Adrenergic and Dopaminergic System in Methylphenidate - induced Motor Activity and Mood-related Alterations in Rats

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 134

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ZUMS-29-137_001

تاریخ نمایه سازی: 1 آبان 1400

چکیده مقاله:

Background and Objective: Methylphenidate (MPH), as a central nervous system stimulant, is often used to manage hyperactive disorders. The literature is scarce regarding the behavioral consequences of chronic MPH treatment and the role of involved receptors. Thus, in the current study involved receptors in MPH induced-anxiety, depression and motor activity disorders were evaluated. Materials and Methods: Seventy rats were randomly distributed to seven groups (n = ۱۰, per group); they were treated with normal saline, Domoic acid (DOM) (as AMPA/kainite receptor agonist), Bicuculline (BIC) (as GABAA receptor antagonist), Ketamine (KET) (as NMDA receptor antagonist ), Yohimbine (YOH) (as Alpha-۲ adrenergic receptor antagonist), or Haloperidole (HAL) (as D۲ dopamine receptor antagonist), simultaneously with MPH (۱۰ mg/kg). On days ۱۱, ۱۷ and ۲۴, some standard behavior tests including Elevated Plus Maze (EPM), Forced Swim Test (FST) and Open Field Test (OFT) were used to investigate anxiety, depression and motor activity disturbances, respectively. Results: Our study indicated that pretreatment of rats with KET, HAL and YOH abolished MPH induced - mood and motor activity disturbances.  Conclusion: MPH by interacting with Dopaminergic, NMDA and ɑ۲-adrenergic receptors induces anxiety, depression and motor activity disorders.

کلیدواژه ها:

Methylphenidate ، Aanxiety ، Depression and Motor activity.

نویسندگان

Kowsar Jahanbakshi

Dept. of Medicine, Qom Branch, Islamic Azad University, Qom, Iran

Sulail Fatima

Dept. of Physiology, Jinnah Medical & Dental College, Sohail University, Karachi, Pakistan

Majid Motaghinejad

Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran

Manijeh Motevalian

Dept. of Medicine, Qom Branch, Islamic Azad University, Qom, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Klein-Schwartz W. Abuse and toxicity of methylphenidate. Curr Opinion Pediatr. ...
  • Yano M , Steiner H. Methylphenidate and cocaine: the same ...
  • Scahill L, Carroll D, Burke K. Methylphenidate: mechanism of action ...
  • Logan B. Methamphetamine-effects on human performance and behavior. Forensic Sci ...
  • Kim Y , Teylan M, Baron M, Sands A, Nairn ...
  • Klein-Schwartz W, McGRATH J. Poison centers' experience with methylphenidate abuse ...
  • Carlezon Jr, Mague W, Andersen SL. Enduring behavioral effects of ...
  • Vendruscolo L , Izídio G, Takahashi R, Ramos A .Chronic ...
  • Riddle EL, Fleckenstein AE, Hanson GR. Mechanisms of methamphetamine-induced dopaminergic ...
  • Martins M , Reinke A, Petronilho F, Gomes K, Dal-Pizzol ...
  • Solleveld M, Schrantee A, Puts N, Reneman L, Lucassen P.Age-dependent, ...
  • Jia Cheng , Zhe Xiong , Lara J Duffney , ...
  • Haenisch B, Bönisch H. Depression and antidepressants: insights from knockout ...
  • Gronier B. In vivo electrophysiological effects of methylphenidate in the ...
  • Rozas C. Methylphenidate amplifies long-term potentiation in rat hippocampus CA۱ ...
  • Furini C, Behling J, Zinn C, Zanini M.Extinction memory is ...
  • Gamo N, Wang M, Arnsten A. Methylphenidate and atomoxetine enhance ...
  • Gill KE, Beveridge T, Smith HR, Porrino LJ.The effects of ...
  • Staff N. Guidelines for the care and use of mammals ...
  • Gould T, Dao D, Kovacsics C. The open field test, ...
  • Can A, Dao DT, Arad M, Terrillion CE, Piantadosi SC, ...
  • Komada M, Takao K, Miyakawa T. Elevated plus maze for ...
  • Challman TD, Lipsky J. Methylphenidate: its pharmacology and uses. in ...
  • Tagaya H. Methylphenidate: pharmacology, indication and potential of abuse. Nihon ...
  • Huss M, Lehmkuhl U. Methylphenidate and substance abuse: a review ...
  • Iliou T, Casta P, Lequeux J, Pochard L, Frauger E, ...
  • Miller EM, Quintero JE, Pomerleau F, Huettl P, Gerhardt GA, ...
  • Koda K, Ago Y, Cong Y, Kita Y, Takuma K, ...
  • Levin ED, Sledge D, Roach S, Petro A, Donerly S, ...
  • Motaghinejad M, Motevalian M. Involvement of AMPA/kainate and GABAA receptors ...
  • Zhang CL, Feng ZJ, Liu Y,et al.Methylphenidate enhances NMDA-receptor response ...
  • Motaghinejad M, Motevalian M, Fatima S. Mediatory role of NMDA, ...
  • Barkus C, McHugh SB, Sprengel R, Seeburg PH, Rawlins JN, ...
  • Racagni G, Popoli M. The pharmacological properties of antidepressants. Int ...
  • Urban KR, Waterhouse BD, Gao WJ. Distinct age-dependent effects of ...
  • Devos D, Moreau C, Delval A, Dujardin K, Defebvre L, ...
  • نمایش کامل مراجع